Approval · Notice of Compliance 12947 · 2012
OLEPTRO: Notice of Compliance 12947
Issued January 20, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12947
- Date
- January 20, 2012
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name Change
- Therapeutic class
- Antidepressant
Products in this notice
Medicinal ingredients
- TRAZODONE HCL 150 MG per TAB
- TRAZODONE HCL 300 MG per TAB